Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
The occurrence of second tumors, such as T-cell lymphomas, post-CAR T-cell therapy is rare. The study identifies Epstein-Barr virus and mutant clonal hematopoiesis as potential factors but finds no evidence of oncogenic retroviral integration, providing valuable insights for clinical practice.
Hematology/Oncology June 17th 2024
Epoch Health
Recent findings suggest extending follow-up colonoscopy intervals to 15 years for patients without a family history of colorectal cancer and with initial negative results. This could reduce unnecessary procedures without significantly increasing cancer risk.
Gastroenterology June 4th 2024
A recent study highlights the role of methylglyoxal (MGO) in temporarily deactivating the BRCA2 protein, crucial for DNA repair and tumor suppression.
Endocrinology, Diabetes, Metabolism June 3rd 2024
“In light of recent findings, it is crucial to evaluate the implications of modified mRNA in therapeutic uses, particularly its role in immune response and potential cancer progression.”
Allergy & Immunology April 29th 2024
Annals of Internal Medicine
In a longitudinal assessment spanning over two decades, researchers found that calcium and vitamin D supplementation in postmenopausal women contributed to a 7% reduction in cancer mortality.
Internal Medicine March 20th 2024
Medical News Today (MNT)
In postmenopausal women, calcium and vitamin D supplementation is a double-edged sword, offering protection against cancer while potentially increasing cardiovascular risk. A nuanced approach to patient consultation is vital to navigate these contrasting outcomes.
Cardiology March 18th 2024